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Abstract
 We recently completed a randomised controlled trial in Goa IndiaBackground:
in which we observed a pattern of discordance with our two primary outcome
measures; the Beck Depression Inventory (BDI-II) classified patients as
moderately severe at the end of treatment, whilst the Patient Health
Questionnaire (PHQ-9) classified these same patients as being only mildly
depressed. The aim of this study is to explore whether the disparity between
these two measures is seen in other settings.
 The relationship between BDI-II and PHQ-9 scores was comparedMethod:
between the Indian trial and two other studies (from United Kingdom and
United States) that administered both measures to patients. Linear regression
was used to quantify the non-concordance between the two measures across
studies. Patients were classified by severity category on the BDI-II and PHQ-9,
respectively, and relationship assessed using chi-square test. We further
quantified the proportion assigned a higher category on the BDI-II than the
PHQ-9 and assessed the difference in prevalence between studies using a test
of proportions.
 Correlations between PHQ-9 and BDI-II were high and similar acrossResults:
studies (India: r=0.79; UK: r=0.87; US: r=0.77). Regression coefficients were
similar across studies, but the predicted BDI-II mean score was significantly
higher in the India study (24.3) compared to the US (20.5) or UK (20.8) studies.
India participants had poorer outcomes on the BDI-II than the PHQ-9 and this
difference was significant relative to both the UK (prevalence difference (PD):
-15.9%; p<0.0001) and US studies (PD: -15.8%; p<0.0001).
 The BDI-II and PHQ-9 measures are highly correlated, but theConclusions:
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  The BDI-II and PHQ-9 measures are highly correlated, but theConclusions:
BDI-II tends to assign high severity scores in an Indian sample compared to
UK/US samples. Where it is necessary to read items to patients, it seems likely
that the PHQ-9 is a more accurate measure given that the BDI-II is longer and
more complex.
Keywords
depression, severity, measurement, global mental health, BDI-II, PHQ-9
 Benedict Weobong ( )Corresponding author: bkweobong@gmail.com
  : Conceptualization, Data Curation, Formal Analysis, Project Administration, Writing – Original Draft Preparation,Author roles: Weobong B
Writing – Review & Editing;  : Data Curation, Formal Analysis, Methodology, Writing – Review & Editing;  : Data Curation,Weiss HA Cameron IM
Methodology, Writing – Review & Editing;  : Data Curation, Methodology, Writing – Review & Editing;  : Data Curation, FundingKung S Patel V
Acquisition, Methodology, Writing – Review & Editing;  : Conceptualization, Methodology, Writing – Review & EditingHollon SD
 No competing interests were disclosed.Competing interests:
 This research was funded by a Wellcome Trust Senior Research Fellowship grant to VP [091834]. BW is supported through anGrant information:
Intermediate Research Fellowship from the Wellcome Trust/India Alliance [502680]. 
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
 © 2018 Weobong B  . This is an open access article distributed under the terms of the  ,Copyright: et al Creative Commons Attribution Licence
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 Weobong B, Weiss HA, Cameron IM   How to cite this article: et al. Measuring depression severity in global mental health: comparing the
 Wellcome Open Research 2018,  :165 (PHQ-9 and the BDI-II [version 1; peer review: 1 not approved] 3
)https://doi.org/10.12688/wellcomeopenres.14978.1
 28 Dec 2018,  :165 ( ) First published: 3 https://doi.org/10.12688/wellcomeopenres.14978.1
Page 2 of 12
Wellcome Open Research 2018, 3:165 Last updated: 24 APR 2019
Introduction
We recently completed a randomised controlled trial in Goa 
India comparing a culturally-adapted version of behavioural acti-
vation called the Healthy Activity Program (HAP) (Chowdhary 
et al., 2016) plus Enhanced Usual Care (EUC) delivered by 
lay counsellors to EUC alone (Patel et al., 2017). The authors 
found that HAP plus EUC was superior to EUC alone in treating 
moderate to severe depression both at the short-term (3-months 
post-randomization) (Patel et al., 2017) and long-term (12-
months post-randomization) (Weobong et al., 2017) in general 
practice settings. Both primary outcome measures of depres-
sion, the revised Beck Depression Inventory (BDI-II) (Beck 
et al., 1996) and the Patient Health Questionnaire (PHQ-9) 
(Spitzer et al., 1999) showed superiority of the HAP plus EUC 
over EUC at both of these time-points. However, we observed a 
pattern of discordance in terms of depression severity between 
our two depression measures at both 3 months and again at 
12 months; the modal patient was at the low end of the moder-
ate range of severity on the BDI-II, whereas the same patient was 
indicated as having only mild residual symptoms on the PHQ-9. 
The aim of this study is to explore this discrepancy, since it has 
implications for how effective HAP is seen in absolute terms 
and as both measures are widely used.
We therefore searched the literature for other studies that 
administered both measures to the same participants and found 
two, one conducted in the United Kingdom (UK) (Cameron et al., 
2011) and the other in the United States (US) (Kung et al., 
2013). We contacted the lead authors of both studies and invited 
them to join us in investigating this discrepancy by virtue of 
sharing their patient level data and both compiled. If one of the 
measures is problematic, then perhaps it should not be used in 
other cultures. This is particularly important given there are 
growing concerns regarding the validity of measures for assess-
ing severity of depression (Cameron et al., 2008; Cameron 
et al., 2011; Reddy et al., 2010), and little by way of evidence 
on the objective psychometric comparison of these outcome 
measures.
Global mental health depends on the use of culturally appropriate 
measures if we are to accurately assess the burden of depression, 
and more importantly improve treatment plans/decision-making. 
In this paper, we address two questions: whether the discrepancy 
in terms of absolute scores observed in the India trial is similar 
in the other two UK and US studies, and whether the proportion 
of patients for whom the BDI-II score observed is classified in 
a higher severity category than the PHQ-9 score differs across 
the studies.
Methods
Only studies that used both the BDI-II and PHQ-9 as measures 
were eligible for the analysis in this paper. Both measures 
are endorsed by the National Institute for Health and Clini-
cal Excellence to measure baseline depression severity and 
responsiveness to treatment in primary care (Smarr & Keefer, 
2011).
Approvals were obtained for the collection and use of the 
primary data (including additional studies such as this study) 
for each of the studies. Consent was also provided by all 
participants in each of the studies involved in this analysis. For 
India, ethics approval was sought from the Indian Council of 
Medical Research, the Sangath Institutional Review Board 
(IRB), and the London School of Hygiene and Tropical Medi-
cine. For UK, ethics approval was sought from the North of 
Scotland Research Ethics Committee. For US, ethics approval 
was sought from Mayo Clinic Department of Psychiatry and 
Psychology IRB.
Participants
The Indian study consisted of 438 participants (a subset seen 
at 3 and 12 months outcome time-points) of either gender 
aged 18–65 with probable diagnoses of moderately severe and 
severe depression based on PHQ-9 scores greater than 14 at 
baseline (Patel et al., 2017). The BDI-II was not administered at 
baseline. Participants were all drawn from a parallel arm com-
parison of HAP plus EUC to EUC alone conducted in 10 primary 
health centres in the state of Goa on the west coast of India. All 
scores were drawn from the 3- and 12-month post-treatment 
assessments at the end of the trial.
The UK sample consisted of 267 participants of either gender 
aged 16 and above with diagnoses of depression as ascertained 
by their general practitioner (Cameron et al., 2011). The study 
compared the performance of three different self-report meas-
ures of depression (the BDI-II and the PHQ-9) with a widely 
used clinician-rated instrument - the Hamilton Rating Scale 
for Depression (Hamilton, 1960). Participants who could not 
read the self-report measures because they were illiterate were 
ineligible for the study.
The US sample consisted of 625 depressed participants of 
either gender, aged 18–76 years (338 inpatients and 287 outpa-
tients) (Kung et al., 2013). The BDI-II and PHQ-9 were collected 
as part of routine clinical care and analysed retrospectively to 
compare their performance in that setting. As in the UK sample 
both scales were self-administered in English by participants 
who could read.
Measures
The BDI-II consists of 21 items covering a number of symptoms 
of depression. Each of the 21 items assess a different symptom 
with four different response options each a full sentence long. 
For example, the first item “Sad” is followed by response options 
ranging from: “0 – I do not feel sad.” “1 – I feel sad much of the 
time.” “2 – I am sad all the time.” “3 – I am so sad or unhappy 
that I can’t stand it” with total scores found by summing the 
highest response to each given item. The BDI-II has strong psy-
chometric properties and historically is the most widely used 
self-report outcome measure of depression in trials. The BDI-II 
defines symptom severity at four levels recommended by Beck 
(Beck et al., 1996), and in reference to the structured clinical 
interview for the Diagnostic and Statistical Manual of Mental 
Disorders, Third edition (Spitzer et al., 1999): 0–13 Minimal 
Depression; 14–19 Mild Depression; 20–28 Moderate Depres-
sion; 29–63 Severe Depression. However, these were based on a 
sample drawn from a primary care site in University of 
Pennsylvania and may not generalize effectively to other primary 
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care settings, particularly in Low and Middle-Income Countries 
(LMIC) (Cameron et al., 2011).
The PHQ-9 is a structured questionnaire that enquires after 
the nine symptom-based criteria for a diagnosis of DSM-IV and 
DSM-5 depression. The instrument presents a common stem 
“Over the past two weeks how often have you been bothered 
by any of the following problems?” and then follows with nine 
specific questions such as “Little interest or pleasure in doing 
things”. Each item is rated on a single four-point scale from “not 
at all” to “nearly every day” and total scores are summed across 
the items. Like the BDI-II, the PHQ-9 has been found to have 
good sensitivity and specificity (Kroenke et al., 2001) and is 
coming into increasing widespread use as a measure of 
depression severity. The PHQ-9 defines symptom severity at 
five levels recommended by Kroenke (Kroenke et al., 2001): 
1–4 Minimal Depression; 5–9 Mild Depression; 10–14 
Moderate Depression; 15–19 Moderately to Severe Depression; 
20–27 Severe Depression.
Procedures
Both scales were administered as self-report instruments in 
the UK and US studies, the standard means of administration, 
and included all 21 items on the BDI-II. In the India study, 
because the vast majority of the participants were illiterate, study 
personnel read the items to the participants and recorded their 
responses in the three major local languages in the study area 
(Konkani/Marathi/Hindi). This followed a rigorous forward and 
back translation process consistent with the five major criteria 
for cross-cultural equivalence in psychiatric research: content 
equivalence, semantic equivalence, technical equivalence, cri-
terion equivalence and conceptual equivalence (Flaherty et al., 
1988). A forward translation was first completed by trained and 
experienced field researchers and these translations reviewed by a 
clinical psychologist fluent in the three local languages, together 
with senior and more experienced research team members, 
at the second stage. Where there were disagreements between 
the clinician and senior research team members on the quality 
of the forward translation, these were discussed with a psychia-
trist with experience of working in both the UK and India-Goa, to 
advise on the concepts captured by the original English wording 
of each item to guide the choice of local language expressions. 
The draft consensus translation was then back-translated into 
English by a bilingual independent non-mental health 
professional, following which further modifications were made 
on the basis of the back-translation, if required. The item inquir-
ing about interest in sex was omitted from the BDI-II in India so 
as not to offend participants. 
Statistical analyses
We first estimated the reliability of each measure using 
Cronbach’s alpha. Following this, we compared scores using 
Pearson product-moment correlation statistics in order to 
ascertain whether both measures were assessing the same construct 
of depression. In order to address our first objective regarding 
the observed discrepancy between the BDI-II and PHQ-9 scores 
in the India trial, we first examined the association between 
scores on the two measures within each study using linear 
regression. Following this, we assessed whether there was 
evidence of moderation by study by fitting an interaction term. 
We then used the predicted BDI-II score and modelled what this 
would be for participants with PHQ-9 score of 10 (moderate 
depression) for each study. Finally, we assessed if the intercepts 
differed between the three studies and generated scatter plots 
of the fitted values for the BDI-II and PHQ-9 for each sample. 
Effect sizes are reported as regression coefficients (with 95% CI) 
for the increase in BDI-II score for each unit increase in PHQ-9 
score. In addition, to address our second objective patients were 
classified with respect to the prespecified depression severity cat-
egorical outcomes on each measure and rates of discordance com-
pared across the studies, and the association was assessed with the 
chi-square statistic. We further explored the number and proportion 
with a higher category on the BDI-II than the PHQ-9 for each 
PHQ-9 category. We ruled out the possibility of temporal effects 
on the observed discrepancy in the India trial at the 3-month 
endpoint, by repeating the regression analysis using follow-up 
data of the same participants on the BDI-II and PHQ-9 at 
12-months post-enrolment. Sensitivity analyses were conducted 
after dropping the sex item on the UK and US studies. 
Statistical analyses were conducted using STATA 15.
Results
A detailed description of the conduct of each study is provided 
in the respective publications (Cameron et al., 2011; Kung 
et al., 2013; Patel et al., 2017).
Reliability
The internal scale consistency (Cronbach’s alpha) for the 
BDI-II and PHQ-9 were high in each study (India: BDI-II=0.91; 
PHQ-9=0.86; UK: BDI-II=0.94; PHQ-9=0.92; US: BDI-II=0.90; 
PHQ-9=0.83).
Construct validity
Correlations between BDI-II and PHQ-9 were high in each 
study (India: r=0.79, 95%CI 0.75-0.82; UK: r=0.87, 95%CI 
0.84-0.90; US: r=0.77. 95%CI 0.73-0.80).
Score distribution
At the 3-month end-point for the India study, the regression 
coefficients were similar for the three studies (India: β=1.58, 
95%CI 1.47-1.70; UK: β =1.58, 95%CI 1.47-1.70; US: β=1.48, 
95%CI 1.39-1.58), and there was no evidence of moderation 
by study (p=0.32). As would be expected given differences in 
the scales, scores on the BDI-II were higher than on the PHQ-9 
in each of the studies, but more so in the India study than in 
the other two (Figure 1). For example, at a PHQ-9 score of 10 
(moderate depression) in the India study, the BDI-II mean 
score was 24.3 (95% CI 23.5, 25.1), and this was significantly 
different from the UK study 20.8 (95%CI 19.6, 21.9) and the 
US 20.5 (95%CI 19.5, 21.4).
Similar results were observed at the 12-month end-point for 
the India sample; the regression coefficient increased slightly 
to (β=1.67, 95%CI 1.56, 1.78) but the greater discrepancy 
between scores in the India study compared to the UK and US 
was maintained (Figure 2). At a PHQ-9 score of 10 (moderate 
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Figure 1. Scatter plot with fitted regression lines of BDI-II and PHQ-9 scores of the three studies (comparison with 3-month outcome 
data in India trial). Plot of regression model fitted with interaction term i.e. allowing slope of PHQ-9 with BDI-II to differ by study.
Figure 2. Scatter plot with fitted regression lines of BDI-II and PHQ-9 scores of the three studies (comparison with 12-month outcome 
data in India trial). Plot of regression model fitted with interaction term i.e. allowing slope of PHQ-9 with BDI-II to differ by study.
depression) in the India sample, the BDI-II mean score was 
23.2 (95% CI 22.4, 23.9), still significantly different from the 
UK and US studies. 
Severity banding
Table 1a–Table 1c show the cross-classification of individual 
participants on each of the categorical values used to describe 
absolute outcomes on the respective measures. As can be seen 
from Table 1a–Table 1c, the participants in the India sample 
were more likely to be classified as having poorer outcomes on 
the BDI-II than the PHQ-9 for each severity band of the PHQ-9, 
and this was significantly different between both the India and 
UK samples (prevalence difference (PD): -15.9%, 95% CI -23.2%, 
-8.7%; p<0.0001) and the India and US samples (PD: -15.8%, 
95% CI -21.9%, -9.5%; p<0.0001).
Results were similar when the sex item was dropped from the 
UK and US studies.
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Table 1b. Comparison of depression severity categories of the BDI-II versus the PHQ-9 in the UK sample 
(N=222) showing row percentages.
PHQ-9 
Categories
BDI-II Categories
Minimal 
Depression 
(score 0-13)
Mild 
Depression 
(score 14-19)
Moderate 
Depression 
(score 20-28)
Severe 
Depression 
(score 29-63)
Total  
PHQ-9 
Category
*n (%)  
BDI-II higher 
category than 
PHQ-9
Minimal 
Depression 
(score 1–4)
35 (88%) 4 (10%) 1 (02%) 0 (00%) 40 (18%) 5/40 (12.5%)
Mild Depression 
(score 5–9)
12 (22%) 27 (49%) 14 (25%) 2 (04%) 55 (25%) 16/55 (29.1%)
Moderate 
Depression 
(score 10–14)
2 (04%) 11 (23%) 23 (48%) 12 (25%) 48 (22%) 12/48 (25.0%)
Moderately 
to Severe 
Depression 
(score 15–19)
2 (05%) 1 (02%) 12 (29%) 27 (64%) 42 (19%) 27/42 (64.3%)
Severe 
Depression 
(score 20–27)
0 (00%) 0 (00%) 0 (00%) 37 (100%) 37 (17%) -
Total BDI 51 (23%) 43 (19%) 50 (23%) 78 (35%) 222 (100%) 60/185 (32.4%) 
*Excluded the highest severity band of the PHQ-9 from this analysis because there was a disproportionate distribution of severe 
depression as assessed by the PHQ-9; the proportion was much higher in the US sample (40%) compared to the India (11%) and 
UK (17%) studies.
Table 1a. Comparison of depression severity categories of the BDI-II versus the PHQ-9 in the India sample 
(N=438) showing row percentages.
PHQ-9 
Categories
BDI-II Categories
Minimal 
Depression 
(score 0-13)
Mild 
Depression 
(score 14-19)
Moderate 
Depression 
(score 20-28)
Severe 
Depression 
(score 29-63)
Total PHQ-9 
Category
*n (%)  
BDI-II higher 
category than 
PHQ-9
Minimal 
Depression 
(score 1-4)
103 (73%) 20 (14%) 13 (09%) 5 (04%) 141 (32%) 38/141 (26.9%)
Mild Depression 
(score 5-9)
20 (24%) 13 (15%) 27 (32%) 24 (29%) 84 (19%) 51/84 (60.7%)
Moderate 
Depression 
(score 10-14)
6 (07%) 12 (14%) 27 (31%) 43 (48%) 88 (20%) 43/88 (48.8%)
Moderately 
to Severe 
Depression 
(score 15-19)
3 (04%) 0 (00%) 11 (14%) 64 (82%) 78 (18%) 64/78 (82.1%)
Severe 
Depression 
(score 20-27)
0 (00%) 0 (00%) 1 (02%) 46 (98%) 47 (11%) -
Total BDI 132 (30%) 45 (10.3%) 79 (18%) 182 (42%) 438 (100%) 196/391 (50.1%) 
*Excluded the highest severity band of the PHQ-9 from this analysis because there was a disproportionate distribution of severe 
depression as assessed by the PHQ-9; the proportion was much higher in the US sample (40%) compared to the India (11%) and 
UK (17%) studies
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Table 1c. Comparison of depression severity categories of the BDI-II versus the PHQ-9 in the US sample 
(N=625) showing row percentages.
PHQ-9 
Categories
BDI-II Categories
Minimal 
Depression 
(score 0-13)
Mild 
Depression 
(score 14-19)
Moderate 
Depression 
(score 20-28)
Severe 
Depression 
(score 29-63)
Total PHQ-9 
Category
*n (%) BDI-II 
higher category 
than PHQ-9
Minimal 
Depression 
(score 1-4)
30 (86%) 4 (11%) 1 (03%) 0 (00%) 35 (6%) 5/35 (14.3%) 
Mild Depression 
(score 5-9)
28 (42%) 17 (25%) 16 (24%) 6 (09%) 67 (11%) 22/67 (32.8%) 
Moderate 
Depression 
(score 10-14)
13 (14%) 16 (17%) 29 (31%) 35 (38%) 93 (15%) 35/93 (37.6%) 
Moderately 
to Severe 
Depression 
(score 15-19)
5 (03%) 8 (05%) 40 (27%) 97 (65%) 150 (24%) 97/150 (64.7%) 
Severe 
Depression 
(score 20-27)
1 (01%) 4 (01%) 25 (09%) 250 (89%) 280 (45%) -
Total BDI 77 (12%) 49 (08%) 111 (18%) 388 (62%) 625 (100%) 159/345 (46.1%) 
*Excluded the highest severity band of the PHQ-9 from this analysis because there was a disproportionate distribution of severe 
depression as assessed by the PHQ-9; the proportion was much higher in the US sample (40%) compared to the India (11%) and 
UK (17%) studies.
Discussion
Patients reported higher severity scores on the BDI-II relative 
to the PHQ-9 in our India sample than they did in either the UK 
or the US. We think this reflects differences in the method of 
administration across the studies; in India, we read the translated 
local language version items to our patients whereas in both the 
UK and the US studies literate patients read the items them-
selves. The BDI-II is a relatively complex instrument that requires 
participants to hold four different options in memory before 
giving a response to each item whereas the PHQ-9 requires only 
that the participants respond with the same simple frequency 
rating to each of its nine items. The BDI-II is sometimes criticized 
for being too transparent to respondents and thus easily faked 
by those wishing to present themselves in a favourable or 
unfavourable light, but that same critique is as likely to apply to 
the PHQ-9 as the BDI-II (Wang & Gorenstein, 2013).
The fact that correlations were high and comparable across 
the samples suggests that both measures were assessing the same 
underlying construct of depression, but the fact that scores on 
the BDI-II were higher relative to the PHQ-9 in our India study 
than in the other two studies suggests that absolute scores on the 
BDI-II are inflated relative to the PHQ-9. Given that partici-
pants in LMICs are often illiterate and would require interviewer 
administration, the PHQ-9 might be preferred over the BDI-II as a 
measure of depression severity. The PHQ-9 is also easily 
accessible as it is free, whereas the BDI-II is only available on 
purchase.
The strengths of this investigation include the cross-cultural 
approach and large sample sizes from well-designed studies. We 
acknowledge some limitations including our inability to account 
for the potential confounding effect of order of administration 
of the two measures (for the India and US studies) and other 
factors such as social desirability, educational attainment and 
sex of respondents (Cronbach, 1990). That being said order of 
administration was largely constant in the India study and though 
this may not have been the case for the US study, the large 
sample size and the randomness of which measure was 
completed first means it is unlikely order effects accounted 
for the differences. Moreover, comparison of the discordance 
among categorical responses on the two measures was complicated 
by the fact that the PHQ-9 defines five categories of depression 
while the BDI-II defines only four (the former adds a “moder-
ately severe to severe” category). However, that difference in 
categorization was consistent across the studies and should 
not have contributed to differences in concordance. Addition-
ally, the level of depression severity in the three studies may have 
influenced our findings. For example, the patients from the 
US study were either from the “Mood Clinic” or “Mood 
Disorder Unit” meaning they were referred or admitted for 
depression treatment. This might explain why the US sample 
had a disproportionately higher band of severely depressed 
PHQ-9. We however dealt with this by dropping this category 
from the analysis comparing the severity bands between the BDI-
II and PHQ-9 in all three studies. Furthermore, we adjusted for 
study in our regression analysis. Finally, even though we strictly 
adhered to principles of cross-cultural psychiatric research in 
adapting the BDI-II and PHQ-9 in the India study, we are unable 
to completely rule out loss of meaning in translation. Admittedly, 
this limitation would apply to both measures though the 
BDI-II would pose more translation challenges given its relative 
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complexity. Dropping the BDI-II item on sex (sexual desire) in 
the India study could have offset its psychometric properties, and 
more importantly for this analysis meant that the samples may 
have been incomparable. However, dropping one item (sex) would 
likely result in lowering the mean score on the BDI-II in the 
India study but in sensitivity analysis we observed in the 
prediction model that in the India study the BDI-II scored people 
higher compared to the PHQ-9, and this was significantly higher 
compared to the UK/US studies. This suggests the robustness 
of our findings without the sex item, and we posit that the 
differences observed would have been much stronger if the 
sex item were maintained in the India study.
It is possible that it was the PHQ-9 that was problematic 
in our sample and not the BDI-II. Ours is the first study to 
examine head-to-head the severity categorisation of the PHQ-
9 and BDI-II, comparing studies from high versus low and 
middle-income settings. The PHQ-9 is the simpler measure and 
places fewer demands on short-term memory than the BDI-II. 
Administering both measures orally in literate samples and see-
ing if that inflates absolute scores on the BDI-II relative to the 
PHQ-9 could resolve this issue. Such a study would be relatively 
easy to conduct and is encouraged given the reported concerns 
regarding the validity of measures for assessing severity of 
depression (Cameron et al., 2008; Hansson et al., 2009; Reddy 
et al., 2010). Until such a study is done we have reservations 
about interpreting absolute values on the BDI-II and prefer to use 
the PHQ-9 instead. It may be the case that the PHQ-9 is more 
suitable as interviewer-administered in illiterate populations 
given findings from a study in Spain that the PHQ-9 performed 
similarly when read out over the phone compared to self- 
administration (Pinto-Meza et al., 2005). What this could mean is 
that studies where illiteracy is a concern, particularly in LMICs, 
researchers might be well advised to use the less complicated 
PHQ-9 than the BDI-II if the scales must be read to illiterate 
participants. Both appear to be valid measures of the 
underlying construct when participants read and complete 
the scales themselves. Further work is required to assess their 
performance when read out to participants. 
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In this manuscript, the authors utilized 3 dataset to examine the concordance between PHQ-9 and BDI-II
scores. Associations were examined dimensionally as were severity categories. Across samples, the two
measures were highly correlated which was similar in each sample. The authors found that BDI-II scores
were higher in the India study versus US and UK studies. Additionally, the India study sample had higher
scores on the BDI-II versus PHQ-9.
I think this manuscript presents an interesting research question, however there are key aspects that
dampen my enthusiasm for it's publication in present form. These include a lack of detail about study
samples, questions about analyses, and the framing of the study/conclusions drawn go beyond the
statistical methods/results employed.
General comments:
1) The authors, at various points, state that the analyses performed indicate that the BDI-II and PHQ-9 are
measuring the same construct. This is a false conclusion that the methods employed do not answer.
Simply because scores are correlated does not mean that the same construct is being studied. If the
authors wish to ask that question, I believe they will have to examine latent variables, i.e., via structural
equation modeling.
2) The participant samples for each respective study are described in detail that prohibits definitive
conclusions from the analyses. For instance, the authors, in the results section, refer readers to the
original papers which is insufficient. 
Introduction:
1) Were the US and UK studies treatment studies? The UK sample is described as participants with
diagnoses of depression but what diagnoses in particular? and how were they evaluated? Though the
measures described (i.e., including Hamilton rating scale) indicate symptoms, I don't think you can say
that they define diagnoses.
2) In the second paragraph, "compiled" should be "complied." Typo.
3) Following sentence, "If one of the measures is problematic..." is a very broad statement. Please be
precise because psychometrically this could mean many a things.
Procedures:
1) Methodologically, it seems troublesome that in the India sample self-report measures (designed to be
self-administered) were answered via question and answer. The authors state in the limitations that
socially desirable responses may have been elicited, which is good, but it remains a big concern. 
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 self-administered) were answered via question and answer. The authors state in the limitations that
socially desirable responses may have been elicited, which is good, but it remains a big concern. 
2) In the statistical analyses, please define "CI."
Results:
1) when comparing within-group scores on the PHQ-9 and BDI-II, why not mean center them? That would
presumably show that the difference between scores within the India study sample is true and not simply
a function of range of scores for each measure.
2) For figures 1 and 2, please use a different legend as it is very difficult to distinguish groups in black and
white printouts. 
3) For the PHQ-9, what is the clinical/practical significance of falling into the minimal depression versus
mild depression categories?
Discussion:
1) The conclusions drawn, from the reader's standpoint, feel like they are hard to justify without further
detail of the samples from which the data are derived.
2) The points made about the BDI-II requiring more working memory because of 4-item choices requires
justification/citation.
3) Beginning of second paragraph: correlation coefficients do not say anything about the underlying
construct. This is problematic in present form.
4) Similarly, higher BDI-II versus PHQ-9 scores in the India study but not others may be
sample-dependent.
5) The comment that if the "sex" item on the BDI-II were included in the India study that observed
differences would be much stronger seems like a stretch. Do people, in generally, commonly endorse the
"sex" item? Are there high rates of sexual dysfunction in the India study sample? I would think in practice
people would be reluctant to answer honestly on that item, particularly in an interview format.
Is the work clearly and accurately presented and does it cite the current literature?
Partly
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
No
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
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